Analyst Price Targets — DMAC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 7, 2024 9:07 am | Bill Chappell | Truist Financial | $10.00 | $4.42 | Benzinga | This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday |
| October 7, 2024 6:05 am | Matthew Caufield | H.C. Wainwright | $7.00 | $4.36 | TheFly | DiaMedica Therapeutics initiated with a Buy at H.C. Wainwright |
| March 21, 2024 9:10 am | Alex Nowak | Craig-Hallum | $8.00 | $2.69 | StreetInsider | DiaMedica Therapeutics Inc. (DMAC) PT Lowered to $8 at Craig-Hallum |
Latest News for DMAC
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth res
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that company management will participate in four upcoming investment bank conferences in New York. Details Citi Biopharma Back to School Summit September 9-10, 2026 Cantor…
The average of price targets set by Wall Street analysts indicates a potential upside of 130% in DiaMedica Therapeutics (DMAC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
DiaMedica Therapeutics (DMAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DMAC.
U.S. House Trading
No House trades found for DMAC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.